Impact of Hemodialysis on Plasma Carnitine Levels in Patients With End Stage Renal Disease

NCT05817799 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

83

Enrollment

OTHER

Sponsor class

Conditions

Hemodialysis Complication

Interventions

DRUG: L-Carnitine 500Mg thrice daily
DRUG: 1g L-Carnitine IV three times a week

Sponsor

Bahria University

Collaborators

[object Object]
[object Object]
[object Object]